World of Bacteria header image

Escherichia coli Nissle 1917 – Probiotic Strain

Escherichia coli Nissle 1917 is a well-characterized non-pathogenic probiotic strain of serotype O6:K5:H1, used for more than a century and studied for its ability to colonize the intestinal environment and antagonize selected enteric pathogens.

Basic Characteristics

Taxonomy

  • Domain: Bacteria
  • Phylum: Pseudomonadota (Proteobacteria)
  • Class: Gammaproteobacteria
  • Order: Enterobacterales
  • Family: Enterobacteriaceae
  • Genus: Escherichia
  • Species: Escherichia coli
  • Strain: Nissle 1917 (DSM 6601)
  • Serotype: O6:K5:H1

Microscopy & Gram Stain

  • Short Gram-negative rods
  • Cells occur mainly singly, with pairs and short arrangements also possible
  • Microscopy does not distinguish Nissle 1917 from pathogenic or other non-pathogenic E. coli strains

Oxygen Relationship

  • Facultatively anaerobic

Rapid Identification Tests

  • Oxidase: negative
  • Catalase: positive
  • Indole: usually positive
  • Motility: positive
  • Lactose fermentation: positive
  • Sorbitol fermentation: positive
  • Haemolysis on blood agar: absent in the illustrated strain

Ecology and Clinical Relevance

Natural Habitat

  • Human intestinal tract during administration and temporary colonization
  • Probiotic pharmaceutical preparations containing the defined Nissle 1917 strain
  • Laboratory cultures used in probiotic, host–microbe, and microbial competition research

Common Laboratory and Study Material

  • Reference and collection cultures
  • Probiotic preparations
  • Experimental mixed cultures with intestinal pathogens
  • Stool specimens collected during colonization or probiotic studies

Biological and Clinical Significance

  • One of the most intensively studied Gram-negative probiotic bacterial strains
  • Used since the early twentieth century in selected gastrointestinal indications
  • Capable of competing with and antagonizing several enteric microorganisms under experimental conditions
  • Its probiotic identity depends on the defined strain and cannot be inferred from ordinary E. coli morphology

Differential Considerations

  • Commensal and pathogenic strains of Escherichia coli
  • Shigella flexneri and other non-lactose-fermenting enteric bacteria on MacConkey agar
  • Shiga toxin-producing and other diarrhoeagenic E. coli pathotypes
  • Strain-level verification is required because routine species identification does not establish Nissle 1917 identity

Diagnostic and Clinical Notes

Escherichia coli Nissle 1917, commonly abbreviated EcN, is a defined probiotic strain of serotype O6:K5:H1 and collection designation DSM 6601. Its ordinary plate and microscopic morphology remain those of E. coli and do not independently reveal its strain identity.

The strain has been used since the early twentieth century and is among the most extensively investigated Gram-negative probiotics. Its biological behaviour reflects a combination of intestinal fitness, competition for nutrients and micronutrients, interactions with the host epithelium, and antagonistic effects against selected microorganisms.

The MacConkey agar images provide two complementary teaching points. Lactose fermentation produces deep pink to red EcN colonies and distinguishes them visually from pale, non-lactose-fermenting Shigella flexneri colonies under the illustrated conditions.

In the experimental mixed culture, S. flexneri colonies remain smaller close to dense Nissle 1917 growth. This is evidence of antagonism in that specific assay, but the visible phenotype should not be generalized into a single mechanism or interpreted as proof of bactericidal activity without additional testing.

Experimental studies have also shown that EcN can interfere with invasion of intestinal epithelial cells by S. flexneri and other invasive pathogens. Such properties are strain-specific and cannot be assigned to unrelated E. coli isolates identified only at species level.

Laboratory Identification

Colony Morphology

On blood agar after 18–24 hours at 35–37 °C, Escherichia coli Nissle 1917 forms smooth, convex, grey-white, non-haemolytic colonies similar to those of many ordinary E. coli strains. On MacConkey agar it ferments lactose and develops pink to red colonies. Neither appearance establishes the Nissle 1917 strain identity.

Microscopy

Gram staining shows short Gram-negative rods, usually occurring singly. Microscopy is indistinguishable from pathogenic, commensal, and other probiotic Escherichia coli strains.

Key Identification Clues

  • Gram-negative rods
  • Facultatively anaerobic growth
  • Oxidase negative and catalase positive
  • Usually indole positive and motile
  • Lactose- and sorbitol-fermenting phenotype
  • Non-haemolytic growth in the illustrated culture
  • Defined strain designation Nissle 1917 / DSM 6601
  • Serotype O6:K5:H1

Modern Identification Methods

Routine MALDI-TOF MS or biochemical identification can establish the species Escherichia coli but ordinarily does not prove that an isolate is Nissle 1917. Reliable strain-level verification requires documented provenance or strain-specific molecular characterization, potentially supported by whole-genome sequencing and comparison with authenticated EcN reference data.

Antibiotic Characteristics

Escherichia coli Nissle 1917 is used as a probiotic strain rather than as an antimicrobial drug, and its antagonistic effects should not be equated with antibiotic treatment.

Antimicrobial susceptibility is a strain property and should be assessed directly whenever relevant to quality control, research, or an unexpected clinical recovery. Ordinary colony morphology does not predict susceptibility.

Species-level identification as E. coli does not confirm probiotic identity or safety. Authenticated strain provenance and appropriate characterization are essential, particularly because unrelated E. coli isolates may carry virulence or acquired antimicrobial-resistance determinants.

Note: Probiotic preparations should be used only according to their authorized product information and appropriate clinical guidance; laboratory observations of antagonism do not establish efficacy for treatment of an individual infection.

External Resources

For broader information about Escherichia coli Nissle 1917, its history, genomic characteristics, and experimentally studied probiotic properties, see: